Back to search results

Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

Abroad (travel likely)RecruitingPHASE4

Conditions

Atrial Fibrillation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Jesse Brown VA Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Sorin Lazar, MD) · slazar1@uic.edu · 312-996-6730
    Contact: Principal Investigator (Sorin Lazar, MD)

  • Rush University Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Henry Huang, MD) · henry_d_huang@rush.edu
    Contact: Principal Investigator (Henry Huang, MD)

  • University of Illinois at Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Dawood J Darbar, M.D.) · darbar@uic.edu · 6158879032
    Contact: Principal Investigator (Dawood Darbar, M.D.)

  • Advocate Christ Medical Center, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Adarsh Bhan, MD) · adarsh.bhan@advocatehealth.com
    Contact: Principal Investigator (Adarsh Bhan, MD)
View source on ClinicalTrials.gov(opens in a new tab)